<code id='F12F4EDF94'></code><style id='F12F4EDF94'></style>
    • <acronym id='F12F4EDF94'></acronym>
      <center id='F12F4EDF94'><center id='F12F4EDF94'><tfoot id='F12F4EDF94'></tfoot></center><abbr id='F12F4EDF94'><dir id='F12F4EDF94'><tfoot id='F12F4EDF94'></tfoot><noframes id='F12F4EDF94'>

    • <optgroup id='F12F4EDF94'><strike id='F12F4EDF94'><sup id='F12F4EDF94'></sup></strike><code id='F12F4EDF94'></code></optgroup>
        1. <b id='F12F4EDF94'><label id='F12F4EDF94'><select id='F12F4EDF94'><dt id='F12F4EDF94'><span id='F12F4EDF94'></span></dt></select></label></b><u id='F12F4EDF94'></u>
          <i id='F12F4EDF94'><strike id='F12F4EDF94'><tt id='F12F4EDF94'><pre id='F12F4EDF94'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:885
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          PhRMA lawsuit over Medicare drug price negotiation tossed

          APStockWASHINGTON—AfederaldistrictjudgeonMondaygrantedtheBidenadministration’srequesttodismissalawsu